Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.15 USD | -1.71% | -11.54% | +29.75% |
Apr. 15 | Faron Pharmaceuticals reappoints former finance chief on interim basis | AN |
Apr. 03 | Top Midday Decliners | MT |
Evolution of the average Target Price on FibroGen, Inc.
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering FibroGen, Inc.
BofA Securities | |
Goldman Sachs | |
Stifel Nicolaus | |
Raymond James | |
William Blair & Co. | |
Cowen | |
SVB Leerink | |
Jefferies & Co. | |
Mizuho Securities | |
HC Wainwright |
EPS Revisions
- Stock Market
- Equities
- FGEN Stock
- Consensus FibroGen, Inc.